Moreover, the physical barrier of VISTA-positive myeloid cells at the tumor periphery suggests a pivotal myeloid–tumor interplay, while the inhibition of T-cell proliferation by tumor cells underscores a T-cell–tumor inhibitory effect driving immune suppression. Here, VSIR is linked to neoplasm.